Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Non-cash Items: 2021-2022

  • Cullinan Therapeutics' Non-cash Items fell 12.93% to $66.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $66.0 million, marking a year-over-year decrease of 12.93%. This contributed to the annual value of $3.7 million for FY2022, which is 13.29% up from last year.
  • Cullinan Therapeutics' Non-cash Items amounted to $66.0 million in Q4 2022, which was down 12.93% from $75.8 million recorded in Q4 2021.
  • In the past 5 years, Cullinan Therapeutics' Non-cash Items registered a high of $75.8 million during Q4 2021, and its lowest value of $66.0 million during Q4 2022.
  • In the last 2 years, Cullinan Therapeutics' Non-cash Items had a median value of $70.9 million in 2021 and averaged $70.9 million.
  • Data for Cullinan Therapeutics' Non-cash Items shows a maximum YoY dropped of 12.93% (in 2022) over the last 5 years.
  • Quarterly analysis of 2 years shows Cullinan Therapeutics' Non-cash Items stood at $75.8 million in 2021, then decreased by 12.93% to $66.0 million in 2022.